MoonLake Immunotherapeutics (NASDAQ MLTX) Revenue and Competitors
Estimated Revenue & Valuation
- MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated annual revenue is currently $10.4M per year.
- MoonLake Immunotherapeutics (NASDAQ MLTX)'s estimated revenue per employee is $155,000
Employee Data
- MoonLake Immunotherapeutics (NASDAQ MLTX) has 67 Employees.
- MoonLake Immunotherapeutics (NASDAQ MLTX) grew their employee count by 81% last year.
MoonLake Immunotherapeutics (NASDAQ MLTX)'s People
Name | Title | Email/Phone |
---|
MoonLake Immunotherapeutics (NASDAQ MLTX) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.1M | 104 | 28% | N/A | N/A |
#2 | $37.4M | 511 | -2% | $250.2M | N/A |
#3 | $60.3M | 389 | -5% | N/A | N/A |
#4 | $31.8M | 205 | 22% | N/A | N/A |
#5 | $1.9M | 12 | 0% | N/A | N/A |
#6 | $2.5M | 16 | -43% | N/A | N/A |
#7 | $7.9M | 51 | 2% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $0.6M | 4 | 0% | N/A | N/A |
#10 | $10.4M | 67 | 81% | N/A | N/A |
What Is MoonLake Immunotherapeutics (NASDAQ MLTX)?
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
keywords:N/AN/A
Total Funding
67
Number of Employees
$10.4M
Revenue (est)
81%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.8M | 67 | -3% | N/A |
#2 | N/A | 68 | 51% | N/A |
#3 | $13.7M | 68 | -1% | N/A |
#4 | $12.5M | 69 | 5% | N/A |
#5 | $13.6M | 72 | -18% | N/A |